Lack of Significant Metabolic Abnormalities in Mice with Liver-Specific Disruption of 11β-Hydroxysteroid Dehydrogenase Type 1

Glucocorticoids (GC) are implicated in the development of metabolic syndrome, and patients with GC excess share many clinical features, such as central obesity and glucose intolerance. In patients with obesity or type 2 diabetes, systemic GC concentrations seem to be invariably normal. Tissue GC con...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lavery, Gareth G., Zielinska, Agnieszka E., Gathercole, Laura L., Hughes, Beverly, Semjonous, Nina, Guest, Phillip, Saqib, Khalid, Sherlock, Mark, Reynolds, Gary, Morgan, Stuart A., Tomlinson, Jeremy W., Walker, Elizabeth A., Rabbitt, Elizabeth H., Stewart, Paul M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Endocrine Society 2012
Gaiak:
Glucocorticoids-CRH-ACTH-Adrenal
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3475725/
https://ncbi.nlm.nih.gov/pubmed/22555437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2012-1019
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak